NO970783D0 - Fremgangsmåte for å hindre endometrialkreft - Google Patents

Fremgangsmåte for å hindre endometrialkreft

Info

Publication number
NO970783D0
NO970783D0 NO970783A NO970783A NO970783D0 NO 970783 D0 NO970783 D0 NO 970783D0 NO 970783 A NO970783 A NO 970783A NO 970783 A NO970783 A NO 970783A NO 970783 D0 NO970783 D0 NO 970783D0
Authority
NO
Norway
Prior art keywords
procedure
endometrial cancer
preventing endometrial
preventing
cancer
Prior art date
Application number
NO970783A
Other languages
English (en)
Norwegian (no)
Other versions
NO970783L (no
Inventor
Susan Margaret Boss
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO970783L publication Critical patent/NO970783L/no
Publication of NO970783D0 publication Critical patent/NO970783D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO970783A 1994-08-22 1997-02-20 Fremgangsmåte for å hindre endometrialkreft NO970783D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29385394A 1994-08-22 1994-08-22
PCT/US1995/010651 WO1996005833A1 (en) 1994-08-22 1995-08-21 Methods of inhibiting endometrial cancer

Publications (2)

Publication Number Publication Date
NO970783L NO970783L (no) 1997-02-20
NO970783D0 true NO970783D0 (no) 1997-02-20

Family

ID=23130867

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970783A NO970783D0 (no) 1994-08-22 1997-02-20 Fremgangsmåte for å hindre endometrialkreft

Country Status (17)

Country Link
EP (1) EP0777476A4 (ja)
JP (1) JPH10504824A (ja)
KR (1) KR970705387A (ja)
AU (1) AU688112B2 (ja)
CA (1) CA2198119A1 (ja)
CZ (1) CZ51897A3 (ja)
FI (1) FI970717A (ja)
HU (1) HUT76890A (ja)
IL (1) IL115022A (ja)
MX (1) MX9701327A (ja)
MY (1) MY113757A (ja)
NO (1) NO970783D0 (ja)
NZ (1) NZ292017A (ja)
RU (1) RU2161964C2 (ja)
TW (1) TW404834B (ja)
WO (1) WO1996005833A1 (ja)
ZA (1) ZA956994B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) * 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
KR20160066490A (ko) * 2014-12-02 2016-06-10 주식회사 씨앤드씨신약연구소 헤테로사이클 유도체 및 그의 용도
CN115825414B (zh) * 2023-01-09 2023-04-25 中国医学科学院北京协和医院 血液或尿液代谢标志物及其在子宫内膜癌早筛中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
BR9406616A (pt) * 1993-04-07 1996-02-06 Ligand Pharm Inc Método para triagem de agonistas receptores
ES2179063T3 (es) * 1993-10-15 2003-01-16 Lilly Co Eli Procedimientos para tratar neoplasmas resistentes.
CA2198120A1 (en) * 1994-08-22 1996-02-29 Robin Sharon Lee Fuchs-Young Methods of inhibiting primary endometrial hyperplasia
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses

Also Published As

Publication number Publication date
EP0777476A1 (en) 1997-06-11
JPH10504824A (ja) 1998-05-12
NZ292017A (en) 2000-07-28
IL115022A0 (en) 1998-06-15
AU3370095A (en) 1996-03-14
TW404834B (en) 2000-09-11
NO970783L (no) 1997-02-20
KR970705387A (ko) 1997-10-09
MY113757A (en) 2002-05-31
CZ51897A3 (en) 1997-06-11
MX9701327A (es) 1997-05-31
HUT76890A (en) 1997-12-29
WO1996005833A1 (en) 1996-02-29
FI970717A0 (fi) 1997-02-20
IL115022A (en) 2000-07-31
RU2161964C2 (ru) 2001-01-20
FI970717A (fi) 1997-02-20
ZA956994B (en) 1997-02-21
EP0777476A4 (en) 1999-06-23
CA2198119A1 (en) 1996-02-29
AU688112B2 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
DK0802183T3 (da) Østrogenforbindelser
DE69527437T2 (de) Drehbarer siphon
DE69513175D1 (de) Hydrathemmung
BR9701879A (pt) Agentes estrogênicos
ID19419A (id) Senyawa-senyawa penghambat sintetase skualena
DK0883404T3 (da) Kombinationsterapi for osteoporosis
NO990307L (no) FremgangsmÕte for logging
NO950275D0 (no) Kombinasjonsbehandling for osteoporose
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
DE59405478D1 (de) Drehdurchführung
NO970783D0 (no) Fremgangsmåte for å hindre endometrialkreft
DK0926953T3 (da) Halogenpropargylinkonklusionskomplekser
NO971029D0 (no) Fremgangsmåter for hemming av endometriale metoser
KR960007681U (ko) 승합차용 선반
KR950022388U (ko) 격재형 4각 어초블록
FI960383A0 (fi) Muuntaja
KR950031410U (ko) 트랜스 훠머용 캡
KR950032837U (ko) 자동차용 후미 콤비네이숀 램프 카버
KR960007857U (ko) 밴용 쿼터 인너 패널
KR960007141U (ko) 라인카
NO960756D0 (no) For
NO964439L (no) Fôr
GB9211094D0 (en) Endometrial resectoscope
KR960021574U (ko) 자동차용 램프
NO983451D0 (no) FremgangsmÕte for hemming av colontumorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application